Racial/Ethnic Disparities in Pathologic Complete Response and Overall Survival in Patients With Triple-Negative Breast Cancer Treated With Neoadjuvant Chemotherapy.

Hannah E WoriaxSamantha M ThomasJennifer K Plichta Oluwadamilola M Fayanju Astrid M Botty Van den BrueleAkiko ChibaE Shelley HwangMaggie L DiNome

Published in: Journal of clinical oncology : official journal of the American Society of Clinical Oncology (2024)

Odds of achieving pCR and OS in patients with TNBC appear to be associated with race/ethnicity. Additional research is necessary to understand how race/ethnicity is associated with rates of pCR and OS, whether related to socioeconomic factors or biologic variables, or both.

Keyphrases

neoadjuvant chemotherapy
locally advanced
lymph node
sentinel lymph node
rheumatoid arthritis
rectal cancer
real time pcr
radiation therapy
free survival
newly diagnosed
affordable care act